Category
CLSI C43-A2 – Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.
This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.
Product Details
- Published:
- 03/01/2010
- ISBN(s):
- 1562387200
- File Size:
- 1 file , 2 MB
- Note:
- This product is unavailable in Russia, Belarus
Related products
-
CLSI VET01
$180.00$108.00Add to cartPerformance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals, Fifth Edition, VET01Ed5E, Includes Update (2019)
Published by Publication Date Number of Pages CLSI 06/29/2018 163 -
CLSI VET05-R (R2018)
$180.00$108.00Add to cartGeneration, Presentation, and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report, VET05RE
Published by Publication Date Number of Pages CLSI 09/01/2011 72 -
CLSI VET09
$180.00$108.00Add to cartUnderstanding Susceptibility Test Data as a Component of Antimicrobial Stewardship in Veterinary Settings, 1st Edition, VET09Ed1E
Published by Publication Date Number of Pages CLSI 07/23/2019 150 -
CLSI VET04
$180.00$108.00Add to cartPerformance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals, 3rd Edition, VET04Ed3E
Published by Publication Date Number of Pages CLSI 05/20/2020 88